Krit Charupanit

Dr. Krit Charupanit

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
LLLongwei Liu
Longwei Liu
PLPraopim Limsakul
Praopim Limsakul
XMXianhui Meng
Xianhui Meng
YHYan Huang
Yan Huang
RHReed E. S. Harrison
Reed E. S. Harrison
YWYingxiao Wang
Yingxiao Wang
The limited sensitivity of Förster Resonance Energy Transfer (FRET) biosensors hinders their broader applications. Here, we develop an approach integrating high-throughput FRET sorting and next-generation sequencing (FRET-Seq) to identify sensitive biosensors with varying substrate sequences from large-scale libraries directly in mammalian cells, utilizing the design of self-activating FRET (saFRET) biosensor. The resulting biosensors of Fyn and ZAP70 kinases exhibit enhanced performance and enable the dynamic imaging of T-cell activation mediated by T cell receptor (TCR) or chimeric antigen receptor (CAR), revealing a highly organized ZAP70 subcellular activity pattern upon TCR but not CAR engagement. The ZAP70 biosensor elucidates the role of immunoreceptor tyrosine-based activation motif (ITAM) in affecting ZAP70 activation to regulate CAR functions. A saFRET biosensor-based high-throughput drug screening (saFRET-HTDS) assay further enables the identification of an FDA-approved cancer drug, Sunitinib, that can be repurposed to inhibit ZAP70 activity and autoimmune-disease-related T-cell activation.

26 July 2017 in Brain Topography
Verified
Journal Article
Closed access
PDF file
KCKrit Charupanit
Krit Charupanit
BLB. A. Lopour
B. A. Lopour

23 May 2022 in Molecules
Verified
Journal Article
Open access
PDF file
KCKrit Charupanit
Krit Charupanit
VTVaromyalin Tipmanee
Varomyalin Tipmanee
TSThana Sutthibutpong
Thana Sutthibutpong
PLPraopim Limsakul
Praopim Limsakul
The accumulation of polyethylene terephthalate (PET) seriously harms the environment because of its high resistance to degradation. The recent discovery of the bacteria-secreted biodegradation enzyme, PETase, sheds light on PET recycling; however, the degradation efficiency is far from practical use. Here, in silico alanine scanning mutagenesis (ASM) and site-saturation mutagenesis (SSM) were employed to construct the protein sequence space from binding energy of the PETase–PET interaction to identify the number and position of mutation sites and their appropriate side-chain properties that could improve the PETase–PET interaction. The binding mechanisms of the potential PETase variant were investigated through atomistic molecular dynamics simulations. The results show that up to two mutation sites of PETase are preferable for use in protein engineering to enhance the PETase activity, and the proper side chain property depends on the mutation sites. The predicted variants agree well with prior experimental studies. Particularly, the PETase variants with S238C or Q119F could be a potential candidate for improving PETase. Our combination of in silico ASM and SSM could serve as an alternative protocol for protein engineering because of its simplicity and reliability. In addition, our findings could lead to PETase improvement, offering an important contribution towards a sustainable future.

3 May 2020 in Epilepsia Open
Verified
Journal Article
Open access
PDF file
KCKrit Charupanit
Krit Charupanit
ISIndranil Sen‐Gupta
Indranil Sen‐Gupta
JLJack J. Lin
Jack J. Lin
BLBeth A. Lopour
Beth A. Lopour
Objective: High‐frequency oscillations (HFOs) are a promising biomarker for the epileptogenic zone. However, no physiological definition of an HFO has been established, so detection relies on the empirical definition of an HFO derived from visual observation. This can bias estimates of HFO features such as amplitude and duration, thereby hindering their utility as biomarkers. Therefore, we set out to develop an algorithm that detects high‐frequency events in the intracranial EEG that are morphologically distinct from background without requiring assumptions about event amplitude or shape.Method: We propose the anomaly detection algorithm (ADA), which uses unsupervised machine learning to identify segments of data that are distinct from the background. We apply ADA and a standard HFO detector using a root mean square amplitude threshold to intracranial EEG from 11 patients undergoing evaluation for epilepsy surgery. The rate, amplitude, and duration of the detected events and the percent overlap between the two detectors are compared.Result: In the seizure onset zone (SOZ), ADA detected a subset of conventional HFOs. In non‐SOZ channels, ADA detected at least twice as many events as the standard approach, including some conventional HFOs; however, ADA also identified many low and intermediate amplitude events missed by the standard amplitude‐based method. The rate of ADA events was similar across all channels; however, the amplitude of ADA events was significantly higher in SOZ channels (P < .0045), and the amplitude measurement was more stable over time than the HFO rate, as indicated by a lower coefficient of variation (P < .0125).Significance: ADA does not require human supervision, parameter optimization, or prior assumptions about event shape, amplitude, or duration. Our results suggest that the algorithm's estimate of event amplitude may differentiate SOZ and non‐SOZ channels. Further studies will examine the utility of HFO amplitude as a biomarker for epilepsy surgical outcome.

19 May 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TJThawirasm Jungrungrueang
Thawirasm Jungrungrueang
SCSawrawit Chairat
Sawrawit Chairat
KRKasidach Rasitanon
Kasidach Rasitanon
PLPraopim Limsakul
Praopim Limsakul
KCKrit Charupanit
Krit Charupanit
Dementia spectrum disorders, characterized by progressive cognitive decline, pose a significant global health burden. Early screening and diagnosis are essential for timely and accurate treatment, improving patient outcomes and quality of life. This study investigated dynamic features of resting-state electroencephalography (EEG) functional connectivity to identify characteristic patterns of dementia subtypes, such as Alzheimer’s disease (AD) and frontotemporal dementia (FD), and to evaluate their potential as biomarkers. We extracted distinctive statistical features, including mean, variance, skewness, and Shannon entropy, from brain connectivity measures, revealing common alterations in dementia, specifically a generalized disruption of Alpha-band connectivity. Distinctive characteristics were found, including generalized Delta-band hyperconnectivity with increased complexity in AD and disrupted phase-based connectivity in Theta, Beta, and Gamma bands for FD. We also employed a convolutional neural network model, enhanced with these dynamic features, to differentiate between dementia subtypes. Our classification models achieved a multiclass classification accuracy of 93.6% across AD, FD, and healthy control groups. Furthermore, the model demonstrated 97.8% and 96.7% accuracy in differentiating AD and FD from healthy controls, respectively, and 97.4% accuracy in classifying AD and FD in pairwise classification. These establish a high-performance deep learning framework utilizing dynamic EEG connectivity patterns as potential biomarkers, offering a promising approach for early screening and diagnosis of dementia spectrum disorders using EEG. Our findings suggest that analyzing brain connectivity dynamics as a network and during cognitive tasks could offer more valuable information for diagnosis, assessing disease severity, and potentially identifying personalized neurological deficits.

1 February 2022 in Journal of Neural Engineering
Verified
Journal Article
Open access
MNMichael D Nunez
Michael D Nunez
KCKrit Charupanit
Krit Charupanit
ISIndranil Sen-Gupta
Indranil Sen-Gupta
BLBeth A Lopour
Beth A Lopour
JLJack J Lin
Jack J Lin
Objective. High frequency oscillations (HFOs) recorded by intracranial electrodes have generated excitement for their potential to help localize epileptic tissue for surgical resection. However, the number of HFOs per minute (i.e. the HFO ‘rate’) is not stable over the duration of intracranial recordings; for example, the rate of HFOs increases during periods of slow-wave sleep. Moreover, HFOs that are predictive of epileptic tissue may occur in oscillatory patterns due to phase coupling with lower frequencies. Therefore, we sought to further characterize between-seizure (i.e. ‘interictal’) HFO dynamics both within and outside the seizure onset zone (SOZ). Approach. Using long-term intracranial EEG (mean duration 10.3 h) from 16 patients, we automatically detected HFOs using a new algorithm. We then fit a hierarchical negative binomial model to the HFO counts. To account for differences in HFO dynamics and rates between sleep and wakefulness, we also fit a mixture model to the same data that included the ability to switch between two discrete brain states that were automatically determined during the fitting process. The ability to predict the SOZ by model parameters describing HFO dynamics (i.e. clumping coefficients and coefficients of variation) was assessed using receiver operating characteristic curves. Main results. Parameters that described HFO dynamics were predictive of SOZ. In fact, these parameters were found to be more consistently predictive than HFO rate. Using concurrent scalp EEG in two patients, we show that the model-found brain states corresponded to (1) non-REM sleep and (2) awake and rapid eye movement sleep. However the brain state most likely corresponding to slow-wave sleep in the second model improved SOZ prediction compared to the first model for only some patients. Significance. This work suggests that delineation of SOZ with interictal data can be improved by the inclusion of time-varying HFO dynamics.